Formulation, nutritional characterization and toxicological safety of a ready-to-use therapeutic food based on peanut, sesame, amaranth seeds and spinach
PDF (French)

Keywords

RUTF
sesame
amaranth
severe acute malnutrition
nutrition
aflatoxins
toxicological safety
Democratic Republic of the Congo

How to Cite

Formulation, nutritional characterization and toxicological safety of a ready-to-use therapeutic food based on peanut, sesame, amaranth seeds and spinach. (2026). REVUE DES SCIENCES DE LA SANTE, 5(2), 797-807. https://doi.org/10.71004/rss.026.v5.i2.126

Abstract

Severe acute malnutrition remains a major public health concern in the Democratic Republic of the Congo. Dependence on imported ready-to-use therapeutic foods (RUTFs) raises concerns regarding accessibility, cost and availability. Valorization of locally available food resources may provide an appropriate alternative for the development of context-specific therapeutic foods. Objective: To formulate and characterize a RUTF based on peanut, sesame, amaranth seeds and spinach, and to assess its nutritional quality and toxicological safety. A comparative experimental study was conducted at the Food Biochemistry and Technology Laboratory of CREN-K. Five formulations (F1–F5), prepared in three independent batches, were evaluated. Proximate composition, energy value, essential amino acids and major minerals were determined. Phytates, oxalates, tannins, hydrogen cyanide (HCN) and aflatoxins were also assessed. Aflatoxin stability was evaluated after six months of storage. Sensory acceptability and the Predictive Index of Nutritional Effectiveness (PINE) were assessed as complementary parameters. Energy density ranged from 524 to 548 kcal/100 g, protein content from 13.6 to 15.8 g/100 g and fat content from 28.2 to 34.6 g/100 g. F4 showed the best nutritional performance, with 548 kcal/100 g, 15.8 g protein and a PINE of 1.000. F5 showed the highest sensory acceptability score (24.65/30; p<0.001). Antinutritional factors were low, while aflatoxin levels remained below 3 µg/kg after six months of storage. These findings demonstrate the feasibility of developing a locally produced RUTF with favorable nutritional and toxicological characteristics. Further studies on nutrient bioavailability, long-term stability and, particularly, clinical efficacy are required before therapeutic implementation.

PDF (French)

References

1. World Health Organization. WHO guideline on the prevention and management of wasting and nutritional oedema (acute malnutrition) in infants and children under 5 years. Geneva: World Health Organization; 2023.

2. World Health Organization. WHO guideline on the dairy protein content in ready-to-use therapeutic foods for treatment of uncomplicated severe acute malnutrition. Geneva: World Health Organization; 2021.

3. Bosonkie M, Mudogo CN, Silverstein H, Fawole OI, Compta G, Ngbolua KT-N, et al. Comparison of the nutritional value of locally formulated food preparations and standard ready-to-use therapeutic foods for the management of uncomplicated severe acute malnutrition in children under five in the Democratic Republic of the Congo. Food Sci Nutr. 2025;13(12):e71302.

4. World Health Organization. WHO guideline on the dairy protein content in ready-to-use therapeutic foods for treatment of uncomplicated severe acute malnutrition. Geneva: World Health Organization; 2021.

5. World Health Organization. Micronutrient intake in children with severe acute malnutrition. Geneva: World Health Organization; 2023.

6. Codex Alimentarius Commission. Guidelines for ready-to-use therapeutic foods (RUTF). Rome: FAO/WHO; 2023. (CXG 95-2022).

7. FAO/WHO Codex Alimentarius. Expert advice on appropriate criteria and limits for contaminants in ready-to-use therapeutic foods. Rome: FAO/WHO; 2018.

8. World Health Organization. WHO guideline on the prevention and management of wasting and nutritional oedema (acute malnutrition) in infants and children under 5 years. Geneva: WHO; 2023.

9. Choudhury N, Ahmed T, Hossain MI, Islam MM, Sarker SA, Zeilani M, et al. Ready-to-use therapeutic food made from locally available food ingredients is well accepted by children having severe acute malnutrition in Bangladesh. Food Nutr Bull. 2018;39(1):116-126.

10. Weber JM, Callaghan M. Optimizing ready-to-use therapeutic foods for protein quality, cost, and acceptability. Food Nutr Bull. 2016;37(1 Suppl):S37-S46.

11. Bosonkie M, Mudogo CN, Silverstein H, Fawole OI, Compta G, Ngbolua KT-N, et al. Comparison of the nutritional value of locally formulated food preparations and standard ready-to-use therapeutic foods for the management of uncomplicated severe acute malnutrition in children under five in the Democratic Republic of the Congo. Food Sci Nutr. 2025;13(12):e71302.

12. Codex Alimentarius Commission. Guidelines for ready-to-use therapeutic foods (RUTF). Rome: FAO/WHO; 2022.

13. Purwestri RC, Scholl C, Wieringa FT, et al. Ready-to-use therapeutic foods based on local recipes are as efficacious and have a higher acceptability than a standard peanut-based RUTF: a randomized controlled trial in Indonesia. Nutrients. 2023;15(15):3385.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Copyright (c) 2026 Makuwa et al.